J&J announces PPP for Investigational Prophylactic HIV Vaccine

Pharma |  News | 0 Comment | 16 Jul, 2019

Johnson & Johnson has announced that Janssen Vaccines & Prevention B.V., one of its Janssen Pharmaceutical Companies, together with a consortium of global partners are preparing to ...Read more

Cipla EU, Jiangsu Acebright enter into Joint Venture

Pharma |  News | 0 Comment | 16 Jul, 2019

Cipla (EU) Limited, a U.K.-based wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited  and Jiangsu Acebright Pharmaceutical Co. Ltd. have announced that t...Read more

Takeda expands India portfolio of rare disease therapies

Pharma |  News | 0 Comment | 15 Jul, 2019

Takeda has announced the launch of its Enzyme Replacement Therapy portfolio for Lysosomal Storage Disorders (LSD) in India in line with its commitment to address the unmet needs of patients...Read more

Bukwang Pharma subsidiary raises 3 billion won

Pharma |  News | 0 Comment | 15 Jul, 2019

Contera Pharma, a Danish subsidiary of South Korea based Bukwang Pharmaceutical, has attracted 3 billion won in Series A from Medici Investments. Conterapa expects JM-010, which is und...Read more

Gilead Sciences, Galapagos enter into deal worth $5B

Pharma |  News | 0 Comment | 15 Jul, 2019

US based Gilead Sciences and Belgian firm Galapagos have announced that they have entered into a 10-year global research and development collaboration. Through this agreement...Read more

Glenmark & Torrent to co-market diabetic drug in India

Pharma |  News | 0 Comment | 12 Jul, 2019

Glenmark Pharmaceuticals Ltd. (Glenmark), and Torrent Pharmaceuticals Limited (Torrent) have announced that they have entered into a non-exclusive sub-licensing agreement to co-market sodiu...Read more

Novena Global Lifecare to expand NOVU Aesthetics and Xingkeduo brands in China and beyond

Pharma |  News | 0 Comment | 12 Jul, 2019

Novena Global Lifecare, one of the world's largest integrated medical healthcare and aesthetic companies with over 100 clinics in 20 cities mainly in the Asia Pacific region, has ...Read more

Yuyu Pharma holds campaign for enhancing corporate transparency

Pharma |  News | 0 Comment | 12 Jul, 2019

Yuyu Pharma, a Korean pharmaceutical company celebrated its third year of implementing Yuyu's compliance management system by inviting senior management to its "Self-Compliance Day" worksho...Read more

MacroGenics and I-Mab to develop, commercialize Enoblituzumab in China

Pharma |  News | 0 Comment | 11 Jul, 2019

MacroGenics, a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, and I-Mab B...Read more

BI announces Dabigatran's safety and efficacy for management of VTE in children

Pharma |  News | 0 Comment | 09 Jul, 2019

Boehringer Ingelheim today announced results from two paediatric studies of dabigatran etexilate, which were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2019...Read more

Lupin launches Imatinib Mesylate tablets

Pharma |  News | 0 Comment | 09 Jul, 2019

Pharma major Lupin Limited (Lupin) announced the launch of Imatinib Mesylate Tablets, 100 mg (base) and 400 mg (base). Lupin’s alliance partner Natco had received an approval from the...Read more

Daewoong Pharmaceutical introduced the excellence of NABOTA® (Prabotulinumtoxin A)

Pharma |  News | 0 Comment | 09 Jul, 2019

Daewoong Pharmaceutical Co., Ltd, a world-leading botulinum toxin manufacturer in Korea, announced its participation in IMCAS Asia 2019 held in Bali, Indonesia from 5-7 July 2019 ...Read more

Wize Pharma retains Lighthouse BioPartners for LO2A

Pharma |  News | 0 Comment | 09 Jul, 2019

Wize Pharma, a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders has announced that it has retained Lighthouse BioPartners, LLC a US-based firm speci...Read more

Glenmark receives ANDA approval for Ranolazine Extended-Release Tablets

Pharma |  News | 0 Comment | 09 Jul, 2019

Glenmark Pharmaceuticals Inc. has been granted final approval by the United States Food & Drug Administration for Ranolazine Extended-Release Tablets, 500 mg and 1,000 mg, a generic ver...Read more

FSD Pharma closes deal and acquires Prismic Pharmaceuticals

Pharma |  News | 0 Comment | 08 Jul, 2019

FSD Pharma and Prismic Pharmaceuticals,  a US-based specialty R&D pharmaceutical company has announced that, on June 28, 2019, they finalized the acquisition by FSD ...Read more

GSK opens new pharma manufacturing facilities with S$130M investment

Pharma |  News | 0 Comment | 08 Jul, 2019

GSK on 5 July 2019, opens new state-of-the-art manufacturing facilities in Singapore following an S$130m investment. The new facilities are located in GSK’s Jurong site and include tw...Read more

21st Interphex Week Japan: Making the event as one of the largest pharma industry events in Asia

Pharma |  Opinion | By Ankit Kankar | 0 Comment | 05 Jul, 2019

5 july 2019 , Tokyo. In Speaking with an official show director of Reed Exhibition , An official summarised an event as below : Close to 45,000 appx  individuals and 1280 Appx Exhibi...Read more

21st Interphex Week Japan concludes in Tokyo

Pharma |  News | By Ankit Kankar | 0 Comment | 05 Jul, 2019

5 July 2019 , Tokyo . Interphex Japan concludes in Tokyo 45,000 appx Visitors from around the world including all concurrent shows . 1280 Appx Exhibitors from 34 countries of world. 300...Read more